Plus Receives $2M Series A for Cannabis-Infused Products
Oct 18, 2017 12:01 pm UTC| Business
PALO ALTO, Calif., Oct. 18, 2017 -- Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing (the “Financing”). The Financing was comprised of $2 Million USD of...
FDA Advisory Committee Scheduled to Review TLANDO™ on January 10, 2018
Oct 18, 2017 12:01 pm UTC| Business
SALT LAKE CITY, Oct. 18, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (“FDA”) has scheduled the Bone, Reproductive and Urologic Drugs...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
Oct 18, 2017 12:01 pm UTC| Business
SAN DIEGO, Oct. 18, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its third quarter...
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC
Oct 18, 2017 12:01 pm UTC| Business
Schlieren, Switzerland, Oct. 18, 2017 -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the...
Ofo Adopts Semtech’s LoRa Technology to Expand Bicycle Tracking Coverage
Oct 18, 2017 12:01 pm UTC| Business
CAMARILLO, Calif., Oct. 18, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that ofo, a leading Chinese bike...
R1 RCM to Release Third Quarter 2017 Results on October 31
Oct 18, 2017 12:01 pm UTC| Business
CHICAGO, Oct. 18, 2017 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced it expects to release financial results for...
Oct 18, 2017 12:00 pm UTC| Business
NEWARK, Calif., Oct. 18, 2017 -- Depomed, Inc. (NASDAQ:DEPO) today announced that Santosh J. Vetticaden, M.D., Ph.D., has joined Depomed as Senior Vice President, Chief Medical and Scientific Officer. “Santosh’s deep...